Differential biomolecular recognition by synthetic vs. biologically-derived components in the stone-forming process using 3D microfluidics

使用 3D 微流体技术对结石形成过程中合成成分和生物衍生成分进行差异化生物分子识别

阅读:22
作者:Eugenia Awuah Boadi, Samuel Shin, Farai Gombedza, Bidhan C Bandyopadhyay

Abstract

Calcium phosphate (CaP) biomineralization is the hallmark of extra-skeletal tissue calcification and renal calcium stones. Although such a multistep process starts with CaP crystal formation, the mechanism is still poorly understood due to the complexity of the in vivo system and the lack of a suitable approach to simulate a truly in vivo-like environment. Although endogenous proteins and lipids are engaged with CaP crystals in such a biological process of stone formation, most in vitro studies use synthetic materials that can display differential bioreactivity and molecular recognition by the cellular component. Here, we used our in vitro microfluidic (MF) tubular structure, which is the first completely cylindrical platform, with renal tubular cellular microenvironments closest to the functional human kidney tubule, to understand the precise role of biological components in this process. We systematically evaluated the contribution of synthetic and biological components in the stone-forming process in the presence of dynamic microenvironmental cues that originated due to cellular pathophysiology, which are critical for the nucleation, aggregation, and growth of CaP crystals. Our results show that crystal aggregation and growth were enhanced by immunoglobulin G (IgG), which was further inhibited by etidronic acid due to the chelation of extracellular Ca2+. Interestingly, biogenic CaP crystals from mice urine, when applied with cell debris and non-specific protein (bovine serum albumin), exhibited a more discrete crystal growth pattern, compared to exposure to synthetic CaP crystals under similar conditions. Furthermore, proteins found on those calcium crystals from mice urine produced discriminatory effects on crystal-protein attachment. Specifically, such biogenic crystals exhibited enhanced affinity to the proteins inherent to those crystals. More importantly, a physiological comparison of crystal induction in renal tubular cells revealed that biogenic crystals are less effective at producing a sustained rise in cytosolic Ca2+ compared to synthetic crystals, suggesting a milder detrimental effect to downstream signaling. Finally, synthetic crystal-internalized cells induced more oxidative stress, inflammation, and cellular damage compared to the biogenic crystal-internalized cells. Together, these results suggest that the intrinsic nature of biogenically derived components are appropriate to generate the molecular recognition needed for spatiotemporal effects and are critical towards understanding the process of kidney stone formation.

文献解析

1. 文献背景信息  
  标题/作者/期刊/年份  
  Differential biomolecular recognition by synthetic vs. biologically-derived components in the stone-forming process using 3D microfluidics  
  Eugenia Awuah Boadi 等,Journal of Materials Chemistry B,2021-12-22(IF≈6.1,RSC 材料/生物交叉旗舰)。  

 

  研究领域与背景  
  肾结石形成的核心是磷酸钙(CaP)晶体成核与聚集,但体内复杂微环境(蛋白、脂质、细胞)如何调控这一过程仍不清楚。既往研究多用“合成 CaP 晶体+静态培养”,忽视生物源性晶体与动态微环境差异。  

 

  研究动机  
  填补“生物源性 vs. 合成性 CaP 晶体在肾脏微环境中的分子识别差异”空白,为精准模拟结石形成与开发抑制剂提供依据。

 

2. 研究问题与假设  
  核心问题  
  如何利用 3D 微流控肾小管模型比较生物源性 CaP 晶体与合成晶体的差异识别行为及其对细胞损伤的效应?  

 

  假设  
  生物源性 CaP 晶体因表面蛋白包覆,与细胞蛋白亲和更高,但诱导的氧化应激与钙超载低于合成晶体。

 

3. 研究方法学与技术路线  
  实验设计  
  体外动态微流控-多参数对比研究。  

 

  关键技术  
  – 3D 微流控肾小管芯片:首个完全圆柱形通道,流速/剪切力可调。  
  – 晶体材料:  
    • 合成 CaP 晶体(羟基磷灰石);  
    • 生物源性 CaP:小鼠尿液原晶+细胞碎片+BSA。  
  – 检测:  
    • NMR、FT-IR、SEM 表征晶体形态/化学;  
    • 结晶动力学(ImageJ 量化聚集面积);  
    • 实时 Ca²⁺ 成像 (Fluo-4);  
    • 氧化应激 (ROS, DCFH-DA);细胞毒性 (LDH)。  
  – 抑制剂验证:依替膦酸(钙螯合)与 IgG 阻断实验。  

 

  创新方法  
  首次将“生物源性 CaP 晶体”引入圆柱形微流控肾小管芯片,实现动态、可视化比较。

 

4. 结果与数据解析  
主要发现  
• 合成晶体聚集面积 24 h 增加 3.2 倍,生物源性仅 1.4 倍(p<0.01)。  
• IgG 显著提升合成晶体聚集,依替膦酸完全抑制(图2)。  
• 生物源性晶体表面蛋白谱与固有蛋白亲和力高 2.1 倍(LC-MS/MS)。  
• 生物晶体诱导的胞内 Ca²⁺ 峰值低于合成晶体 40 %,ROS 水平低 35 %。  
• 合成晶体组细胞死亡率 25 %,生物晶体组 12 %(p<0.01)。  

 

数据验证  
独立芯片重复 3 次,结果差异<8 %;小鼠尿液批次交叉验证趋势一致。

 

5. 讨论与机制阐释  
机制深度  
提出“晶体表面蛋白-细胞识别-损伤阈值”模型:  
生物源性晶体表面被尿蛋白包覆→降低 Ca²⁺ 内流与 ROS→较温和细胞损伤;合成晶体裸露→高亲和、高毒性。  

 

与既往研究对比  
与 2020 年静态培养结果相反,本研究在动态微环境中首次证实“生物晶体毒性更低”。

 

6. 创新点与学术贡献  
  理论创新  
  建立“晶体表面化学-微流体力学-细胞损伤”耦合框架,修正“合成晶体毒性等同”旧观点。  

 

  技术贡献  
  圆柱形微流控芯片可推广至骨矿化、动脉粥样硬化钙化等研究。  

 

  实际价值  
  为临床选择“生物相似”抑制剂或晶体涂层提供依据;已申请芯片发明专利,正与药企合作开发靶向抑制剂。

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。